These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 37203389)

  • 21. Study on Multi-Target Synergistic Treatment of Alzheimer's Disease Based on Metal Chelators.
    Yang A; Wu J; Chen Y; Shen R; Kou X
    Curr Drug Targets; 2023; 24(2):131-150. PubMed ID: 36165518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clawing back: broadening the notion of metal chelators in medicine.
    Franz KJ
    Curr Opin Chem Biol; 2013 Apr; 17(2):143-9. PubMed ID: 23332666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanoparticle delivery of transition-metal chelators to the brain: Oxidative stress will never see it coming!
    Bonda DJ; Liu G; Men P; Perry G; Smith MA; Zhu X
    CNS Neurol Disord Drug Targets; 2012 Feb; 11(1):81-5. PubMed ID: 22229318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minding metals: tailoring multifunctional chelating agents for neurodegenerative disease.
    Perez LR; Franz KJ
    Dalton Trans; 2010 Mar; 39(9):2177-87. PubMed ID: 20162187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The metal ion hypothesis of Alzheimer's disease and the anti-neuroinflammatory effect of metal chelators.
    Chen LL; Fan YG; Zhao LX; Zhang Q; Wang ZY
    Bioorg Chem; 2023 Feb; 131():106301. PubMed ID: 36455485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemical and biological considerations in the treatment of metal intoxications by chelating agents.
    Andersen O
    Mini Rev Med Chem; 2004 Jan; 4(1):11-21. PubMed ID: 14754439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanoparticles derived from naturally occurring metal chelators for theranostic applications.
    Jung W; Lee DY; Moon E; Jon S
    Adv Drug Deliv Rev; 2022 Dec; 191():114620. PubMed ID: 36379406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of 1,10-phenanthroline and its analogues, other chelators and transition metal ions on dipeptidase activity of the rumen bacterium, Prevotella ruminicola.
    Wallace RJ; McKain N
    J Appl Bacteriol; 1996 Jul; 81(1):42-7. PubMed ID: 8675483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The antimicrobial and immunomodulatory effects of Ionophores for the treatment of human infection.
    Li G; De Oliveira DMP; Walker MJ
    J Inorg Biochem; 2022 Feb; 227():111661. PubMed ID: 34896767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of polyaminocarboxylate metal chelators on iron-thiolate induced oxidation of methionine- and histidine-containing peptides.
    Zhao F; Yang J; Schöneich C
    Pharm Res; 1996 Jun; 13(6):931-8. PubMed ID: 8792435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Membrane sensors based on Schiff bases as chelating ionophores--a review.
    Al Zoubi W; Al Mohanna N
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Nov; 132():854-70. PubMed ID: 24947440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metal ions, Alzheimer's disease and chelation therapy.
    Budimir A
    Acta Pharm; 2011 Mar; 61(1):1-14. PubMed ID: 21406339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives.
    Fasae KD; Abolaji AO; Faloye TR; Odunsi AY; Oyetayo BO; Enya JI; Rotimi JA; Akinyemi RO; Whitworth AJ; Aschner M
    J Trace Elem Med Biol; 2021 Sep; 67():126779. PubMed ID: 34034029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small molecule modulators of copper-induced Abeta aggregation.
    Hindo SS; Mancino AM; Braymer JJ; Liu Y; Vivekanandan S; Ramamoorthy A; Lim MH
    J Am Chem Soc; 2009 Nov; 131(46):16663-5. PubMed ID: 19877631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploiting Cancer Metal Metabolism using Anti-Cancer Metal- Binding Agents.
    Merlot AM; Kalinowski DS; Kovacevic Z; Jansson PJ; Sahni S; Huang ML; Lane DJR; Lok H; Richardson DR
    Curr Med Chem; 2019; 26(2):302-322. PubMed ID: 28685681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges and Opportunities of Metal Chelation Therapy in Trace Metals Overload-Induced Alzheimer's Disease.
    Chaudhari V; Bagwe-Parab S; Buttar HS; Gupta S; Vora A; Kaur G
    Neurotox Res; 2023 Jun; 41(3):270-287. PubMed ID: 36705861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chelation in metal intoxication.
    Flora SJ; Pachauri V
    Int J Environ Res Public Health; 2010 Jul; 7(7):2745-88. PubMed ID: 20717537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening, separation and identification of metal-chelating peptides for nutritional, cosmetics and pharmaceutical applications.
    Echavarría JAC; El Hajj S; Irankunda R; Selmeczi K; Paris C; Udenigwe CC; Canabady-Rochelle L
    Food Funct; 2024 Apr; 15(7):3300-3326. PubMed ID: 38488016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ionophores as Potent Anti-malarials: A Miracle in the Making.
    Bharti H; Singal A; Raza M; Ghosh PC; Nag A
    Curr Top Med Chem; 2019; 18(23):2029-2041. PubMed ID: 30499390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation of cyclo-phen-type ligands: chelators of metal ions as potential therapeutic agents in the treatment of neurodegenerative diseases.
    Boldron C; Van der Auwera I; Deraeve C; Gornitzka H; Wera S; Pitié M; Van Leuven F; Meunier B
    Chembiochem; 2005 Nov; 6(11):1976-80. PubMed ID: 16208731
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.